Therapy Areas: Respiratory
Tenaya Therapeutics welcomes June Lee MD to board
23 November 2021 -

Biotechnology company Tenaya Therapeutics Inc (NASDAQ:TNYA) reported on Monday the addition of June Lee, MD, to its board of directors.

The company added that JJ Kang, PhD will resign from board after five years of service to focus on her current role as CEO of Appia Bio and Venture Partner at The Column Group. Dr Kang has served as the company's board member 2016 as well as interim president for two years.

More recently, Dr Lee was the founder and CEO of Esker Therapeutics as well as executive vice president, chief development officer and chief operating officer of MyoKardia.

Previously, Dr Lee was the therapeutic area head for early clinical development in cardiovascular, metabolism, respiratory and infectious diseases at Genentech.

Currently, Dr Lee is a member of the Advisory Board for Johns Hopkins University Center for Therapeutic Translation, board of director for Eledon Pharmaceuticals Inc and GenEdit, as well as the Scientific Advisory Board for Foresite Labs, respectively.

Login
Username:

Password: